Jpmorgan Chase & CO Optimize Rx Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Optimize Rx Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,783 shares of OPRX stock, worth $34,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,783
Previous 112,533
93.08%
Holding current value
$34,400
Previous $1.13 Million
94.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OPRX
# of Institutions
89Shares Held
12.2MCall Options Held
800Put Options Held
18.1K-
First Light Asset Management, LLC Edina, MN1.81MShares$8.01 Million1.22% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$5.2 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1.07MShares$4.74 Million1.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA953KShares$4.21 Million0.0% of portfolio
-
Blair William & CO Chicago, IL677KShares$2.99 Million0.02% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $79.7M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...